Showing results (2981-2990 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|May 16, 2019
Expression of the PTEN/FOXO3a/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progressionQiubo Zhang, Xuanna Li, Yaqing Li, et al.
Investigational New Drugs|May 16, 2019
Zelnorm, an agonist of 5-Hydroxytryptamine 4-receptor, acts as a potential antitumor drug by targeting JAK/STAT3 signalingLei Zhang, Qiaoling Song, Xinxin Zhang, et al.
Investigational New Drugs|September 1, 1988
Phase II trial of menogaril in advanced colorectal cancerE E Holdener, W W ten Bokkel Huinink, G Decoster, et al.
Investigational New Drugs|May 23, 2018
Phase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancerR S Finn, D H Ahn, M M Javle, et al.
Investigational New Drugs|August 1, 2018
HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancerAlexandra Canonici, Laura Ivers, Neil T Conlon, et al.
Investigational New Drugs|October 26, 2021
FX1, a BCL6 inhibitor, reactivates BCL6 target genes and suppresses HTLV-1-infected T cellsChie Ishikawa, Naoki Mori
Investigational New Drugs|October 11, 2021
Efficacy and safety of mitoxantrone hydrochloride liposome injection in Chinese patients with advanced breast cancer: a randomized, open-label, active-controlled, single-center, phase II clinical trialLeiping Wang, Jun Cao, Chunlei Li, et al.
Investigational New Drugs|September 25, 2021
Relapsing polychondritis after treatment with PD-1 blockadeTatsuya Ogimoto, Hironori Yoshida, Masanobu Mizuta, et al.
Investigational New Drugs|September 25, 2021
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib studyKyaw Z Thein, Daniel D Karp, Apostolia Tsimberidou, et al.
Investigational New Drugs|July 14, 2022
Real-world data on efficacy and safety of azacitidine therapy in chronic myelomonocytic leukemia in China: results from a multicenter, retrospective studyYu Xu, Rong Guo, Miao Miao, et al.
Pageof 372